Hemangioma of intracranial structures
ICD-10 D18.02 is a billable code used to indicate a diagnosis of hemangioma of intracranial structures.
Hemangiomas of intracranial structures are benign vascular tumors that arise from the proliferation of blood vessels within the cranial cavity. These tumors can occur in various locations, including the brain and the meninges, and are often discovered incidentally during imaging studies for other conditions. While most hemangiomas are asymptomatic and do not require treatment, some may cause symptoms due to their size or location, leading to increased intracranial pressure, seizures, or neurological deficits. The exact etiology of intracranial hemangiomas remains unclear, but they are generally considered benign and have a low risk of malignant transformation. Surveillance through regular imaging may be necessary for larger or symptomatic lesions to monitor for any changes in size or symptoms. Treatment options, when indicated, may include surgical resection or embolization, particularly if the hemangioma is symptomatic or growing. Overall, the prognosis for patients with hemangiomas of intracranial structures is favorable, with most individuals experiencing a good quality of life.
Detailed neurological examination findings, imaging reports, and treatment plans.
Patients presenting with headaches, seizures, or neurological deficits.
Ensure that imaging studies are clearly documented to support the diagnosis.
Surgical notes, pre-operative assessments, and post-operative follow-up documentation.
Patients requiring surgical intervention for symptomatic hemangiomas.
Document the rationale for surgical intervention and any complications.
Used when a hemangioma requires surgical intervention.
Operative report detailing the procedure and findings.
Neurosurgeons should document the indication for surgery and any complications.
Common symptoms include headaches, seizures, and neurological deficits, which may arise depending on the size and location of the hemangioma.
Patients with asymptomatic hemangiomas may require follow-up imaging every 1-2 years to monitor for changes in size or symptoms.
